Bristol-Myers Squibb and Pfizer announced Tuesday the European Commission has approved their anti-clotting drug Eliquis, the first regulatory approval for the medicine designed to prevent strokes and systemic embolisms.
Get our email newsletters
Stay up-to-date on the companies, people and issues that impact businesses in Hartford and beyond.